The major objective of this course is to provide a detailed insight into the practical aspects and approaches of process scale-up for different unit operations and technologies.
The ugly truth about being beautiful
Cosmetic testing that uses animals is notably controversial. Dripping chemicals into the eyes, shaving the fur and deliberate irritation to skin, long exposure to potential carcinogens or dangerous substances without pain relief drugs…
Even if not tested, products often include substances like animal fat, fish scales, hormones, stomach enzymes, gelatin, liver oil, animal gland steroids, wax and honey or even shark and turtle oil.
The European Union took a step forward in March 2013, when a new law was fully implemented and made it illegal to sell animal-tested cosmetics in Europe, even if the testing was done outside Europe. However, vivisection (experimentation on live animals) continues. 1,170,326 signatures were collected, but the initiative to stop vivisection was denied by the EU Commission.
Despite the remarkable progress that’s been made, ingredients used in cosmetics may still be tested on animals in the EU under REACH, the world’s largest chemical testing programme. Also testing on animals for household products continues. And when you Google cosmetic companies that still test on animals, around 330 names come up!
Scientists should follow the three Rs in order to reduce the impact of research on animals: Reduction, Refinement and Replacement. Reducing the number of animals used in experiments and refining the experiment in a way that the animal suffers as little as possible should be commonplace when they can't abstain from the use of animals. But the third “R” is the best way to go – replacement with alternative methods such as in-vitro testing, research with human volunteers or test tube methods.
Products in Europe that are not tested on animals carry the symbol of the “Leaping Bunny”. Take action, look for information, sign petitions and check what products you are buying. #becrueltyfree
Interested in this topic?
Targeted Drug Delivery
Gain detailed overview of the newest strategies in drug delivery and targeting.
Next Generation Antibody Therapeutics
This focused 2-day training will cover the discovery, engineering and production of next-generation antibodies, antibody fragments, bispecific Abs, innovative ADCs and more. Follow the path from their discovery and selection through engineering and expression to production and regulatory issues.
White Paper: Beyond the Cold Chain
Take a Good Look at the Future of Corporate Universities
There are four things corporate universities can do to avoid becoming irrelevant in the digital age.
Ready for the new GCP ICH E6 (R2) addendum?
On the 23rd of July 2015, the EMA's Committee for Human Medicinal Products released the Guideline for Good Clinical Practice E6(R2) for consultation. On the 14th of June 2017, it will come into effect and influence everyone involved in the clinical research process. What does it mean to pharma and biotech companies, sponsors, CROs, research institutes and third-party organizations?